19.97

0.10% -0.02

Shoulder Innovations Inc (SI)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

$19.99

Offen:

$19.9

24-Stunden-Volumen:

21,301

Relative Volume:

0.18

Marktkapitalisierung:

$414.82M

Einnahmen:

Nettoeinkommen (Verlust:

KGV:

-0.6666

EPS:

-29.96

Netto-Cashflow:

1W Leistung:

-3.25%

1M Leistung:

-3.01%

6M Leistung:

+49.14%

1J Leistung:

+33.31%

1-Tages-Spanne:

$19.64

$20.24

1-Wochen-Bereich:

$19.64

$21.16

52-Wochen-Spanne:

$10.92

$24.59

Shoulder Innovations Inc Stock (SI) Company Profile

Firmenname

Shoulder Innovations Inc

Sektor

Healthcare (1087)

Branche

Medical Devices (141)

Telefon

616-566-0286

Adresse

1535 STEELE AVENUE SW, SUITE B, GRAND RAPIDS

Mitarbeiter

Twitter

Nächster Verdiensttermin

2026-08-06

Neueste SEC-Einreichungen

SI's Discussions on Twitter

Compare SI vs ABT, MDT, SYK, BSX, EW

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
SI Shoulder Innovations Inc	19.93	416.17M	0	0	0	0.00
ABT Abbott Laboratories	105.79	182.59B	46.59B	5.41B	7.38B	3.0938
MDT Medtronic Plc	92.36	118.18B	36.36B	4.84B	5.43B	3.7261
SYK Stryker Corp	272.51	106.03B	25.27B	3.34B	4.57B	8.6334
BSX Boston Scientific Corp	45.17	65.19B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	86.17	49.99B	6.30B	1.07B	1.09B	1.8406

Shoulder Innovations Inc Stock (SI) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-08-25	Eingeleitet	BTIG Research	Buy
2025-08-25	Eingeleitet	Goldman	Buy
2025-08-25	Eingeleitet	Jefferies	Buy
2025-08-25	Eingeleitet	Piper Sandler	Overweight
2023-03-06	Herabstufung	Compass Point	Neutral → Sell
2023-03-06	Herabstufung	Wedbush	Neutral → Underperform
2023-03-02	Herabstufung	Canaccord Genuity	Buy → Hold
2023-03-02	Herabstufung	Compass Point	Buy → Neutral
2023-03-02	Herabstufung	JP Morgan	Neutral → Underweight
2023-03-01	Herabstufung	Keefe Bruyette	Outperform → Mkt Perform
2023-01-09	Herabstufung	Wedbush	Outperform → Neutral
2023-01-06	Herabstufung	BofA Securities	Neutral → Underperform
2023-01-06	Herabstufung	Craig Hallum	Buy → Hold
2023-01-06	Herabstufung	JP Morgan	Overweight → Neutral
2022-12-12	Bestätigt	Wedbush	Outperform
2022-12-05	Herabstufung	Morgan Stanley	Equal-Weight → Underweight
2022-11-21	Hochstufung	Wells Fargo	Underweight → Equal Weight
2022-11-10	Herabstufung	BofA Securities	Buy → Neutral
2022-10-26	Herabstufung	Goldman	Buy → Neutral
2022-10-06	Herabstufung	Wells Fargo	Overweight → Underweight
2022-08-04	Eingeleitet	BTIG Research	Buy
2022-06-13	Eingeleitet	Wells Fargo	Overweight
2022-06-09	Fortgesetzt	Morgan Stanley	Equal-Weight
2022-03-21	Eingeleitet	BofA Securities	Buy
2022-01-20	Hochstufung	Goldman	Neutral → Buy
2021-12-16	Eingeleitet	B. Riley Securities	Buy
2021-11-11	Eingeleitet	JP Morgan	Overweight
2021-11-08	Herabstufung	Keefe Bruyette	Outperform → Mkt Perform
2021-09-27	Eingeleitet	Morgan Stanley	Overweight
2021-06-14	Eingeleitet	Goldman	Neutral
2021-01-14	Herabstufung	Barclays	Overweight → Equal Weight
2020-12-22	Eingeleitet	Wedbush	Outperform
2020-12-17	Hochstufung	Keefe Bruyette	Mkt Perform → Outperform
2020-12-02	Eingeleitet	Craig Hallum	Buy
2020-10-16	Eingeleitet	Compass Point	Buy
2020-03-16	Eingeleitet	Canaccord Genuity	Buy
2019-12-03	Eingeleitet	Keefe Bruyette	Mkt Perform
2019-12-02	Eingeleitet	Barclays	Overweight
2019-11-18	Eingeleitet	Compass Point	Buy

Alle ansehen

Shoulder Innovations Inc Aktie (SI) Neueste Nachrichten

09:06 AM

Catalyst OrthoScience Announces Settlement of Patent Litigation with Shoulder Innovations - Business Wire

09:06 AM

Sep 08, 2026

Shoulder Innovations Announces Settlement of Patent Litigation with Catalyst OrthoScience - Ortho Spine News

Sep 08, 2026

Shoulder Innovations settles patent dispute with Catalyst By Investing.com - Investing.com India

Sep 08, 2026

Shoulder Innovations Settles Patent Dispute With Catalyst OrthoScience - marketscreener.com

Sep 08, 2026

Shoulder Innovations settles patent dispute with Catalyst - Investing.com

Sep 08, 2026

Sep 01, 2026

Shoulder Innovations to Participate in the Morgan Stanley 24th Annual Healthcare Conference - Morningstar

Sep 01, 2026

Shoulder Innovations to present at Morgan Stanl... - Pluang

Sep 01, 2026

Morgan Stanley healthcare conference sets Sept. 15 chat with Shoulder Innovations - Stock Titan

Sep 01, 2026

Aug 28, 2026

Shoulder Innovations (SI) holder trims stake with 1,196-share sale - Stock Titan

Aug 28, 2026

Aug 24, 2026

Gilde Healthcare holding B.V. sells $567k in Shoulder Innovations stock - Investing.com Nigeria

Aug 24, 2026

Shoulder Innovations Reports Second Quarter 2026 Financial Results and Raises Full Year Outlook - Eastern Progress

Aug 24, 2026

Aug 23, 2026

Shoulder (SI) Financial Results: Profit Per Share Clears Its Benchmark; Market Response: Shares Close 0.18% Lower in the Latest ReadingEarnings Whisper Number - vinanet.vn

Aug 23, 2026

Aug 20, 2026

Shoulder (SI) Earnings Snapshot: The Bottom-Line Figure Beats Its Comparison in Latest Trading; Closing Move: Shares Finish 4.99% LowerEarnings Decline Risk - vinanet.vn

Aug 20, 2026

Aug 18, 2026

Shoulder Innovations (NYSE:SI) COO Matthew Fraser Ahearn Sells 8,314 Shares of Stock - MarketBeat

Aug 18, 2026

Gilde Healthcare sells $213,479 of Shoulder Innovations stock By Investing.com - Investing.com UK

Aug 17, 2026

Aug 14, 2026

SHOULDER INNOVATIONS, INC. SEC Filing (Aug 14, 2026) - Stock Titan

Aug 14, 2026

Aug 13, 2026

Shoulder Innovations Promotes Jon Osborne to Chief Commercial Officer - AOL.com

Aug 13, 2026